NP-10679 | m-entrepreneurship.com

Product Name :
NP-10679

Search keywords :
NP10679

drugId :
null

Target Vo:
Glutamate [NMDA] receptor subunit epsilon 2

Target Vo Short Name :
NMDAR2B

Moa_Name:
Glutamate [NMDA] receptor subunit epsilon 2 antagonists

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Neurop Inc

Active Company_Name :
Neurop Inc

Active Indication_Name:
Pain, Postoperative

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Phase 1 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Favezelimab Autophagy
Rozanolixizumab site
Phospho-Smad3 (Ser423/425) Antibody: Phospho-Smad3 (Ser423/425) Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 48 kDa, targeting to Phospho-Smad3 (Ser423/425). It can be used for WB,IHC-P,ICC/IF assays with tag free, in the background of Human, Mouse.

Author: Betaine hydrochloride

Related Posts